三个皮匠报告
最新
报告分类 研搜
BETA
政策库
自研报告
new
入驻
搜索
您的当前位置：首页 > 行业数据 > rESP与rhEPO在血液透析慢性肾衰竭贫血患者中具备相似疗效及安全性
图片属性
图片格式：PNG 图片大小：787KB 图片尺寸：1852*771
同报告图片
 / 4
rESP与rhEPO在血液透析慢性肾衰竭贫血患者中具备相似疗效及安全性_第1页
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
rESP与rhEPO在血液透析慢性肾衰竭贫血患者中具备相似疗效及安全性_第2页
rESP与rhEPO在血液透析慢性肾衰竭贫血患者中具备相似疗效及安全性_第3页
rESP与rhEPO在血液透析慢性肾衰竭贫血患者中具备相似疗效及安全性_第4页
rESP与rhEPO在血液透析慢性肾衰竭贫血患者中具备相似疗效及安全性_第5页
所属报告： 三生制药-港股公司研究报告-核心品种稳健增长创新管线迈入收获期-250217（35页）.pdf
打包全文图表

相关数据

最新数据
全行业研究报告分享下载平台
  • 0731-84720580
  • 商务合作：really158d
关于我们
更多
关于我们
三个皮匠报告微信公众号
三个皮匠报告微信小程序
扫码咨询网站充值下载问题
copyright@2008-2013 长沙景略智创信息技术有限公司版权所有        网站备案/许可证号：湘B2-20190120 | 工信部备案号：湘ICP备17000430号-2 | 公安备案号：湘公网安备43010402001071号
客服
商务合作
小程序
服务号
折叠